Patent details
LUC00139 Product Name: Plérixafor éventuellement sous la forme d'un sel pharmaceutiquement acceptable ou un complexe métallifère qui en dérive
Basic Information
- Publication number:
- LUC00139
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP101845097
- Legal Status:
- Invalid
- Application number:
- LUC00139
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/09/537/001
- Marketing Authorization Type:
- Marketing Authorization Date:
- 04/08/2009
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 26/11/2019
- First Marketing Authorization date:
- 04/08/2009
- Grant date:
- 10/02/2021
- Activation date:
- 30/07/2022
- Publication date:
- 27/11/2019
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 04/08/2024
- SPC Extension Expiration:
- 04/08/2024
- Rejection date:
- Withdrawal date:
Owner
- From:
- 26/11/2019
- Name:
- Genzyme Corporation
- Address:
- 50 Binney Street, Cambridge, MA 02142, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 26/11/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2019/13
- Publication date:
- 20/12/2019
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2021/04
- Publication date:
- 08/03/2021
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2022/09
- Publication date:
- 01/08/2022
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
4
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2024/12
- Publication date:
- 01/10/2024
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 11/07/2024
- Last Annual Fee Paid Number:
- 23
- Last Annual Fee Paid Amount:
- 430 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 26/11/2019 | Application Form | 4 |
| 26/11/2019 | General Document | 15 |
| 26/11/2019 | General Document | 4 |
| 10/02/2021 | Outgoing Correspondence | 1 |
| 27/11/2019 | Outgoing Correspondence | 1 |
| 10/02/2021 | Certificate | 1 |
| 10/01/2020 | Outgoing Correspondence | 1 |
| 10/02/2021 | Publication | 1 |
| 07/01/2020 | Incoming Correspondence (Post) | 1 |
| 26/11/2019 | Incoming Correspondence (Post) | 1 |
| 07/01/2020 | General Document | 3 |
| 27/11/2019 | Publication | 1 |
| 26/11/2019 | General Document | 25 |
| 07/01/2020 | General Document | 3 |